While further work will be required to elucidate the precise mechanism at play, the observed efficacy without increasing baseline blood glucose levels may be highly significant in enabling novel therapies.
← all excerpts
Gcg-XTEN: an improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose.
1
—
—